Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fate Therapeutics
Institut Paoli-Calmettes
Cancer Research UK
OHSU Knight Cancer Institute
Fate Therapeutics
NKGen Biotech, Inc.
Orano Med LLC
Jonsson Comprehensive Cancer Center
ARCAGY/ GINECO GROUP